Author

Florian Selt

German Cancer Research CenterORCID 0000-0001-9717-6712Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 2 Research Focus:cancer & tumor microenvironment· 1 Research Focus:differential expression· 1 Approach:experimental assay· 1 Organism:human· 1 Organism:mouse· 1 Approach:statistical model· 1

Frequent Co-Authors

Olaf WittiD· 2 shared Till MildeiD· 2 shared Akang Leonard Bassey· 1 shared Andreas von DeimlingiD· 1 shared Andrey KorshunoviD· 1 shared Ashley Vardon· 1 shared Bastiaan B.J. TopsiD· 1 shared Christof Maria KrammiD· 1 shared

Activity by Year

2021-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 30 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCancer Biology

Olaf WittORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Cancer BiologyNeuro-OncologyPeer-reviewedOct 28, 2026

Standard treatment against paediatric BRAF-V600E glioma promotes senescence and sensitizes tumours to BCL-xL inhibition

Romain Guiho, Hiba Hamdi, Grace Cooksley…·Juan Pedro Martinez Barbera

This study shows that standard therapies for paediatric BRAF-V600E glioma induce senescence, which can be targeted by BCL-xL inhibitors to prevent tumour regrowth.

DOI 10.1093/neuonc/noag270

mousebulk RNA-seq

𝕏 PostBluesky

GenomicsbioRxivPreprintApr 30, 2021

Distribution of GOPC:ROS1 and other ROS1 fusions in glioma types

Philipp Sievers, Damian Stichel, Martin Sill…·Felix Sahm

The paper identifies ROS1 fusions in various glioma types through genomic and transcriptomic analysis, showing they are not restricted to specific subtypes.

1 citation

humanbulk RNA-seq

𝕏 PostBluesky